orphan drugs

Deep Dive: R&D Innovation

https://pharmaphorum.com/r-d/pharma-research-rare-diseases-0219/

Preliminary Attendee List Released for Orphan Drugs & Rare Diseases Conference

https://pharmaphorum.com/partner-content/preliminary-attendee-list-released-for-orphan-drugs-rare-diseases-conference/

Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018

https://pharmaphorum.com/partner-content/only-4-weeks-until-orphan-drugs-rare-diseases-2018/

Carina Schey, University of Groningen, Orphan Drugs & Rare Diseases Chair Invitation

https://pharmaphorum.com/partner-content/carina-schey-university-of-groningen-orphan-drugs-rare-diseases-chair-invitation/

Why AI and blockchain are the solutions to developing orphan drug

https://pharmaphorum.com/views-analysis-digital/blockchain-solution-developing-orphan-drug/

How challenges like Brexit & insufficient patients hinder Rare Diseases research

https://pharmaphorum.com/partner-content/how-challenges-like-brexit-insufficient-patients-hinder-rare-diseases-research/

Orphan Drugs & Rare Diseases 2018

https://pharmaphorum.com/events/orphan-drugs-rare-diseases-2018/

https://pharmaphorum.com/partner-content/smis-biosimilars-biobetters-exclusive-interview-with-dr-michel-mikhail-released/

Patient Organisations role in Orphan Drugs clinical development

https://pharmaphorum.com/partner-content/patient-organisations-role-in-orphan-drugs-clinical-development/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search